Takeda Pharmaceuticals, the Cambridge-based U.S. subsidiary of the Japanese drugmaker, announced it will lay off 137 employees next year due to the discontinuation of its cell therapy program.

This move is separate from the nearly 1,000 cuts made last year as part of a multi-year efficiency plan.

On Wednesday, Takeda notified the state Executive Officer of Labor and Workforce that it is laying off 137 employees beginning in January at its three locations: 650 Kendall St., 40 Landsdowne St., and 300 Massachusetts Ave.

The notice says the company will provide affected employees with severance packages, and each employee will get a 60-day notice.

A Takeda spokesperson says some employees who received notice last year have continued working for the company in different roles.

Takeda rem

See Full Page